Trademark: KRAZATI 2194055
Word
KRAZATI
ID
2194055
Trademark Type
Word
Status
Registered: Registered/protected
Application Date
13 July 2021
Registration Date
13 July 2021
Renewal Date
13 July 2031
Owner(s)
Service
Knightsbridge Patent Attorneys
Goods and Services:
Class 5:
Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of non-small cell lung carcinoma; pharmaceutical preparations for the treatment of colorectal carcinoma; ; pharmaceutical preparations for the treatment of pancreatic cancer; pharmaceuticals comprising small molecules; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of infectious diseases; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of non-small cell lung carcinoma; ; pharmaceuticals comprising small molecules for the treatment of colorectal carcinoma; pharmaceuticals comprising small molecules for the treatment of pancreatic cancer; pharmaceuticals comprising compounds; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors; pharmaceuticals for the treatment of advanced solid tumors; ; Pharmaceutical formulations, including pharmaceutical formulations for the treatment of cancer or infectious diseases, pharmaceutical formulations comprising small molecules, and pharmaceutical formulations comprising inhibitors
Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of non-small cell lung carcinoma; pharmaceutical preparations for the treatment of colorectal carcinoma; ; pharmaceutical preparations for the treatment of pancreatic cancer; pharmaceuticals comprising small molecules; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of infectious diseases; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of non-small cell lung carcinoma; ; pharmaceuticals comprising small molecules for the treatment of colorectal carcinoma; pharmaceuticals comprising small molecules for the treatment of pancreatic cancer; pharmaceuticals comprising compounds; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors; pharmaceuticals for the treatment of advanced solid tumors; ; Pharmaceutical formulations, including pharmaceutical formulations for the treatment of cancer or infectious diseases, pharmaceutical formulations comprising small molecules, and pharmaceutical formulations comprising inhibitors
Class 42:
Research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals; ; Pharmaceutical research and development services, including conducting pharmaceutical research and/or development on behalf of others; medical and scientific research relating to pharmaceuticals, including conducting clinical trials on behalf of others; the provision of any one or more of these services (including one or more aspects of them) on-line, including via a global communications or telecommunications network, such as the Internet
Research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals; ; Pharmaceutical research and development services, including conducting pharmaceutical research and/or development on behalf of others; medical and scientific research relating to pharmaceuticals, including conducting clinical trials on behalf of others; the provision of any one or more of these services (including one or more aspects of them) on-line, including via a global communications or telecommunications network, such as the Internet